Cashman, Neil R.

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics

Amyotrophic Lateral Sclerosis ResearchAngiogenesis and VEGF in Cancer

Cited by 1,007

Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis

Wang, M.-D., Little, J., Gomes, J., Cashman, N. R., & Krewski, D. (2017) · NeuroToxicology

Amyotrophic Lateral Sclerosis ResearchAmyloidosis: Diagnosis, Treatment, Outcomes

Cited by 233

Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers

Mackenzie, I. R. A., Frick, P., Grässer, F. A., Gendron, T. F., Petrucelli, L., Cashman, N. R., Edbauer, D., Kremmer, E., Prudlo, J., Troost, D., et al. (2015) · Acta Neuropathologica

Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative Diseases

Cited by 231

De novo design of a β -helix tau protein scaffold: An oligomer-selective vaccine immunogen candidate for Alzheimer’s disease

Aina, A., Hsueh, S. C. C., Gibbs, E., Peng, X., Cashman, N. R., & Plotkin, S. S. (2023) · ACS Chemical Neuroscience

Alzheimer's disease research and treatmentsProtein Structure and Dynamics

Cited by 8

Optimizing Epitope Conformational Ensembles Using α-Synuclein Cyclic Peptide “Glycindel” Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson’s Disease

Hsueh, S. C. C., Aina, A., Roman, A. Y., Cashman, N. R., Peng, X., & Plotkin, S. S. (2022) · ACS Chemical Neuroscience

Parkinson's Disease Mechanisms and TreatmentsProtein Structure and Dynamics

Cited by 8

Optimizing epitope conformational ensembles using α -synuclein cyclic peptide “glycindel” scaffolds: A customized immunogen method for generating oligomer-selective antibodies for Parkinson’s disease

Hsueh, S. C. C., Aina, A., Roman, A. Y., Cashman, N. R., Peng, X., & Plotkin, S. S. (2021) · ACS Chemical Neuroscience

Parkinson's Disease Mechanisms and TreatmentsProtein Structure and Dynamics

Cited by 8